Roopom brings a unique combination of strategic and financial advisory, strategy consulting, operating and technical experience to serve life science and technology clients.
Most recently, Roopom was the President and CEO of RainDance Technologies (acquired by BioRad Labs), a venture-backed life science company pioneering the field of liquid biopsy for the detection of cancer from a blood test. Previously, he was a Director of Healthcare Investment Banking at Leerink Swann, where he led the Life Science Tools & Diagnostics sector, and with McKinsey and Goldman Sachs advising Fortune 500 healthcare companies globally on corporate and growth strategy, product development, alliances, mergers and acquisitions. He has successfully completed over 60 transactions including private financings, IPOs, Follow-ons, PIPE/RDs, and Debt/Fixed income as well as M&A.
- Executive Chairman of Saga Diagnostics
- Executive Chairman of Ribbon BioLabs
- Director at Comera Life Sciences
- Director at TwiXimo